HDFC Life’s shares surged 9.60% following Q3FY25 results, wherein the insurance company posted a 15% net profit increase. Analysts are positive, with CLSA and Jefferies maintaining buy ratings. HSBC expects margin improvements as credit protection sales increase and low-margin product growth slows.

Nomura India, which had downgraded HDFC Life to neutral in Q2 due to expected impact of surrender value in Q3, said the current valuation captures the negatives adequately. This brokerage upgraded the HDFC Life stock to 'Buy'.

Shares of HDFC Life Insurance witnessed a significant rally in todays trading session, climbing as much as 12% since yesterdays close. The stocks saw this surge after the company reported a strong financial performance for the quarter ending December 2024 (Q3 FY25).

Revenue decreased by 35.66% YoY & profit increased by 14.63% YoY, profit at ₹421.31 crore and revenue at ₹17389.85 crore

India's HDFC Life Insurance reported a 14% rise in third-quarter profit on Wednesday, helped by growth in the sales of retail insurance policies. The company, the first major Indian life insurer to report its quarterly results,

HDFC Life's share price today rose nearly 10% on January 16, 2025, after the company reported its impressive quarterly results for Q3 FY25. Private insurer HDFC

HSBC expects HDFC Life's focus on new customer acquisition and expanding distribution to support future growth.

HDFC Life Insurance stock soars 12% after strong financial results, with majority of brokerages bullish on 'buy' rating.

HDFC Life shares today zoomed after the private insurance company reported strong results in Q3. HDFC Life in Q3 FY2025 reported 14 per cent rise in net profit to Rs 415 crore.

The growth in profit after tax (PAT) was driven by a record 24 per cent rise in HDFC Life's individual annual premium equivalent (APE).